Drugs.com - New Drug Approvals

Bavarian Nordic Receives U.S. FDA Approval of Jynneos Freeze-Dried Smallpox and Mpox Vaccine

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of Jynneos® (Smallpox and Mpox Vaccine, Live, Non-replicating)...

May 12, 2025 - 10:14
 0
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of Jynneos® (Smallpox and Mpox Vaccine, Live, Non-replicating)...
Read More

Tags:

Previous Article

Uplizna (inebilizumab-cdon) is Now the First and Only FDA-Approved Treatment for...

Next Article

FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A or B With or Without Inhi...

Related Posts

FDA Approves Mezofy (aripiprazole) Oral Film for the Treatment of Schizophrenia

FDA Approves Mezofy (aripiprazole) Oral Film for the Tr...

May 12, 2025  0

FDA Approves an Updated Label for Tryvio (aprocitentan)...

May 12, 2025  0

FDA Approves Vykat XR (diazoxide choline) to Treat Hype...

May 12, 2025  0